|
|
Other links at Articles > Allergy and Clinical Immunology |
| 2. |
CLARITY Trial of Oral Cladribine in MS Meets Primary End Point
|
|
|
A phase 3 trial of oral cladribine in relapsing-remitting MS has met its primary end point of a 58% reduction in annualized relapse rates with the low dose and a 55% reduction with the high dose of the agent, Merck Serono announced. The company plans to apply for regulatory approval in mid-2009, the first application for an oral MS treatment. Medscape Medical News
|
| 4. |
Chronic Aspiration Shifts Th1 Immune Response to Th2, Typical of Asthma
|
|
|
Chronic gastric acid aspiration, as occurs with gastroesophageal reflux disease (GERD), "has a profound effect on the nature of the immune response to aerosolized allergens" in a mouse model of airway hypersensitivity, Duke University researchers have shown. Reuters Health Information
|
| 5. |
H1N1 Flu Skepticism Demands Deft Response
|
|
|
European scientists and health authorities are facing angry questions about why H1N1 flu has not caused death and destruction on the scale first feared, and they need to respond deftly to ensure public support. Reuters Health Information
|
|
|